Novel mouse model for carcinoembryonic antigen-based therapy

Molecular Therapy

Volumn 9, Issue 6, 2004, Pages 775-785

  Chan, Carlos H F ^a   Stanners, Clifford P ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Bacterial artificial chromosome; Carcinoembryonic antigen; CD66 antigens; CEACAM6; Gene therapy; Immunotherapy; Infection; Neoplasms; Preclinical drug evaluation; Transgenic mice

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BACTERIAL INFECTION; BREAST; CONTROLLED STUDY; DISEASE MODEL; DRUG SCREENING; DRUG TARGETING; GASTROINTESTINAL TRACT; GENE CLUSTER; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE OVEREXPRESSION; HEMATOPOIETIC SYSTEM; HUMAN VERSUS ANIMAL COMPARISON; LEUKEMIA; MOUSE; MULTIGENE FAMILY; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FAMILY; RESPIRATORY SYSTEM; SOLID TUMOR; TRANSGENIC MOUSE; UROGENITAL SYSTEM;

ANIMALS; ANTIGENS, CD; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; CELL ADHESION MOLECULES; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION; HUMANS; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; MULTIGENE FAMILY; TISSUE DISTRIBUTION;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS MUSCULUS; NEISSERIA; NEISSERIA GONORRHOEAE; RODENTIA; STAPHYLOCOCCUS PHAGE 187;

EID: 3042773829     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2004.03.009     Document Type: Article

References (50)

1. Ribas A. Butterfield L.H. Glaspy J.A. Economou J.S. Current developments in cancer vaccines and cellular immunotherapy J. Clin. Oncol. 21 2003 2415-2432
2. von Mehren M. Adams G.P. Weiner L.M. Monoclonal antibody therapy for cancer Annu. Rev. Med. 54 2003 343-369
3. Goldenberg D.M. Advancing role of radiolabeled antibodies in the therapy of cancer Cancer Immunol. Immunother. 52 2003 281-296
4. Trail P.A. King H.D. Dubowchik G.M. Monoclonal antibody drug immunoconjugates for targeted treatment of cancer Cancer Immunol. Immunother. 52 2003 328-337
5. Kellen J.A. Gene therapy in cancer J. Exp. Ther. Oncol. 2 2002 312-316
6. Marshall J. Carcinoembryonic antigen-based vaccines Semin. Oncol. 30 2003 30-36
7. Kousparou C.A. Epenetos A.A. Deonarain M.P. Antibody-guided enzyme therapy of cancer producing cyanide results in necrosis of targeted cells Int. J. Cancer 99 2002 138-148
8. Chester K.A. et al. Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer Cancer Chemother. Pharmacol. 46 2000 S8-S12
9. Fong L. et al. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy Proc. Natl. Acad. Sci. USA 98 2001 8809-8814
10. Koch P.E. Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system Mol. Ther. 3 2001 278-283
11. Hammarström S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues Semin. Cancer Biol. 9 1999 67-81
12. Stanners C.P. Cell Adhesion and Communication Mediated by the CEA Family: Basic and Clinical Perspectives1 1998 Harwood Academic Amsterdam
13. Ballesta A.M. Molina R. Filella X. Jo J. Gimenez N. Carcinoembryonic antigen in staging and follow-up of patients with solid tumors Tumour Biol. 16 1995 32-41
14. Chevinsky A.H. CEA in tumors of other than colorectal origin Semin. Surg. Oncol. 7 1991 162-166
15. Mizobata S. Tompkins K. Simpson J.F. Shyr Y. Primus F.J. Induction of cytotoxic T cells and their antitumor activity in mice transgenic for carcinoembryonic antigen Cancer Immunol. Immunother. 49 2000 285-295
16. Wilkinson R.W. et al. Evaluation of a transgenic mouse model for anti-human CEA radioimmunotherapeutics J. Nucl. Med. 43 2002 1368-1376
17. Xu X. et al. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein Cancer Res. 60 2000 4475-4484
18. Oriuchi N. et al. Antibody-dependent difference in biodistribution of monoclonal antibodies in animal models and humans Cancer Immunol. Immunother. 46 1998 311-317
19. Schölzel S. et al. Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas Am. J. Pathol. 156 2000 595-605
20. Hansen L. Meyer K. Hokland P. Flow cytometric identification of myeloid disorders by asynchronous expression of the CD14 and CD66 antigens Eur. J. Haemotol. 61 1998 339-346
21. + early-B-cell malignancies Tissue Antigens 52 1998 1-8
22. Nagel G. et al. Genomic organization, splice variants and expression of CGM1, a CD66-related member of the carcinoembryonic antigen gene family Eur. J. Biochem. 214 1993 27-35
23. Thompson J. et al. Long-range chromosomal mapping of the carcinoembryonic antigen (CEA) gene family cluster Genomics 12 1992 761-772
24. Brandriff B.F. et al. Order and genomic distances among members of the carcinoembryonic antigen (CEA) gene family determined by fluorescence in situ hybridization Genomics 12 1992 773-779
25. Dewar K. Birren B.W. Abderrahim H. Bacterial artificial chromosomes and animal transgenesis In Houdebine L.M. (Ed.), Transgenic Animals: Generation and Use 1997 283-287 Harwood Academic Amsterdam
26. Cournoyer D. Beauchemin N. Boucher D. Benchimol S. Fuks A. Stanners C.P. Transcription of genes of the carcinoembryonic antigen family in malignant and nonmalignant human tissues Cancer Res. 48 1988 3153-3157
27. Yamahita K. Kobata A. Cancer cells and metastasis: carcinoembryonic antigen and related normal antigens In: Montreuil J. Vliegenthart J.F.G. Schachter H. (Eds.), Glycoproteins and Disease 1996 229-239 Elsevier Amsterdam
28. Watt S.M. et al. CD66 identifies a neutrophil-specific epitope within the hematopoietic system that is expressed by members of the carcinoembryonic antigen family of adhesion molecules Blood 78 1991 63-74
29. Eades-Perner A.-M. et al. Mice transgenic for human carcinoembryonic antigen gene maintain its spatiotemporal expression pattern Cancer Res. 54 1994 4169-4176
30. Clarke P. Mann J. Simpson J.F. Richard-Dickson K. Primus F.J. Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy Cancer Res. 58 1998 1469-1477
31. Koops D. Thompson J. Zimmermann W. Stanners C.P. Transcriptional regulation of the non-specific cross-reacting antigen gene, a member of the carcinoembryonic antigen gene family up-regulated in colorectal carcinomas Eur. J. Biochem. 253 1998 778-786
32. Huxley C. Exploring gene function: use of yeast artificial chromosome transgenesis Methods 14 1998 199-210
33. Kim U.-J. et al. Construction and characterization of a human bacterial artificial chromosome library Genomics 34 1996 213-218
34. Song J. Dong F. Lilly J.W. Stupar R.M. Jiang J. Instability of bacterial artificial chromosome (BAC) clones containing tandemly repeated DNA sequences Genome 44 2001 463-469
35. Burke J.M. Jurcic J.G. Scheinberg D.A. Radioimmunotherapy for acute leukemia Cancer Control 9 2002 106-113
36. Ilantzis C. Demarte L. Screaton R.A. Stanners C.P. Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation Neoplasia 4 2002 151-163
37. Soeth E. et al. Controlled ribozyme targeting demonstrates an antiapoptotic effect of carcinoembryonic antigen in HT29 colon cancer cells Clin. Cancer Res. 7 2001 2022-2030
38. Ordoñez C. Screaton R.A. Ilantzis C. Stanners C.P. Human carcinoembryonic antigen functions as general inhibitor of anoikis Cancer Res. 60 2000 3419-3424
39. Wirth T. Soeth E. Czubayko F. Juhl H. Inhibition of endogenous carcinoembryonic antigen (CEA) increases the apoptotic rate of colon cancer cells and inhibits metastatic tumor growth Clin. Exp. Metastasis 19 2002 155-160
40. Kim J.C. Gong G. Roh S.A. Park K.C. Carcinoembryonic antigen gene and carcinoembryonic antigen expression in the liver metastasis of colorectal carcinoma Mol. Cell 9 1999 133-137
41. Leconte A. et al. Involvement of circulating CEA in liver metastases from colorectal cancers re-examined in a new experimental model Br. J. Cancer 9 1999 1373-1379
42. Dehio C. Gray-Owen S.D. Meyer T.F. The role of neisserial Opa proteins in interactions with host cells Trends Microbiol. 6 1998 489-495
43. Skubitz K.M. Campbell K.D. Skubitz A.P.N. Synthetic peptides from the N-domains of CEACAMs activate neutrophils J. Pept. Res. 58 2001 515-526
44. Nair K.S. Zingole S.M. Adhesion of neutrophils to fibronectin: role of the CD66 antigens Cell. Immunol. 208 2001 96-106
45. Kuijpers T.W. et al. CD66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endothelial cells J. Cell Biol. 118 1992 457-466
46. Filella X. et al. Influence of AFP, CEA and PSA on the in vitro production of cytokines Tumor Biol. 22 2001 67-71
47. Gangopadhyay A. Bajenova O. Kelly T.M. Thomas P. Carcinoembryonic antigen induced cytokine expression in Kupffer cells: implications for hepatic metastasis from colorectal cancer Cancer Res. 56 1996 4805-4810
48. Zhou H. Stanners C.P. Fuks A. Specificity of anti-carcinoembryonic antigen monoclonal antibodies and their effects on CEA-mediated adhesion Cancer Res. 53 1993 3817-3822
49. Screaton R.A. Penn L.Z. Stanners C.P. Carcinoembryonic antigen, a human tumor marker, cooperates with Myc and Bcl-2 in cellular transformation J. Cell Biol. 137 1997 939-952
50. Hornbeck P. Enzyme-linked immunosorbent assays Coligan J.E. Kruisbeek A.M. Margulies D.H. Shevach E.M. Strober W. Current Protocols in Immunology 1991 2.1.2-2.1.22 Greene Publishing and Wiley-Interscience New York